SCHEMBL3404038

SCHEMBL3404038

O=C(CO)Oc1ccccc1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
HPGD P15428 1/20 0.46
HRH1 P35367 7/20 0.46
L3MBTL1 Q9Y468 2/20 0.44
DRD2 P14416 1/20 0.44
DRD1 P21728 1/20 0.44
DRD4 P21917 1/20 0.44
DRD5 P21918 1/20 0.44
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
SLC5A1 P13866 1/20 0.43
SLC5A2 P31639 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1345320 0.85 HRH1 (0.51) SMN1; SMN2HPGDHRH1L3MBTL1DRD2
SCHEMBL5478147 0.84 HPGD (0.50) SMN1; SMN2HPGDHRH1L3MBTL1DRD2
SCHEMBL5478146 0.84 HPGD (0.50) SMN1; SMN2HPGDHRH1L3MBTL1DRD2
SCHEMBL11607227 0.81 HPGD (0.47) SMN1; SMN2HPGDHRH1L3MBTL1DRD2
SCHEMBL27644538 0.81 HPGD (0.51) SMN1; SMN2HPGDHRH1L3MBTL1DRD2
SCHEMBL531084 0.81 PTGS2 (0.54) SMN1; SMN2HPGDHRH1L3MBTL1DRD2
SCHEMBL28886357 0.80 L3MBTL1 (0.46) HPGDL3MBTL1TSHR
SCHEMBL28860367 0.78 HPGD (0.45) SMN1; SMN2HPGDHRH1L3MBTL1DRD2
SCHEMBL4342753 0.77 THRA (0.57) SMN1; SMN2HPGDHRH1L3MBTL1DRD2
SCHEMBL30778391 0.77 HRH1 (0.47) SMN1; SMN2HPGDHRH1L3MBTL1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10675278-B2 Crush resistant delayed-release dosage forms Grünenthal GmbH (DE) 2020-06-09 US disclosed
US-20180369235-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2018-12-27 US disclosed
US-20170312271-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2017-11-02 US disclosed
US-9750701-B2 Pharmaceutical dosage form Grünenthal GmbH (DE) 2017-09-05 US disclosed
US-20160199305-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2016-07-14 US disclosed
US-20160184297-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2016-06-30 US disclosed
US-20160120810-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS Grünenthal GmbH (DE) 2016-05-05 US disclosed
US-20150374630-A1 Crush resistant delayed-release dosage forms GRUENENTHAL GMBH (DE) 2015-12-31 US disclosed
US-20150290138-A1 Crush resistant delayed-release dosage forms Grünenthal GmbH (DE) 2015-10-15 US disclosed
US-20140322323-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2014-10-30 US disclosed
US-20140322311-A1 CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM Grünenthal GmbH (DE) 2014-10-30 US disclosed
US-20140079780-A1 Crush resistant delayed-release dosage forms GRUENENTHAL GMBH (DE) 2014-03-20 US disclosed
US-20130251759-A1 PHARMACEUTICAL DOSAGE FORM GRUENENTHAL GMBH (DE) 2013-09-26 US disclosed
US-8383152-B2 Pharmaceutical dosage form GRUENENTHAL GMBH (DE) 2013-02-26 US disclosed
EP-2249811-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2010-11-17 EP disclosed
US-20100151028-A1 CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS GRUNENTHAL GMBH (DE) 2010-06-17 US disclosed
US-20090202634-A1 PHARMACEUTICAL DOSAGE FORM GRUNENTHAL GMBH (DE) 2009-08-13 US disclosed
WO-2009092601-A1 PHARMACEUTICAL DOSAGE FORM Grünenthal GmbH (DE) 2009-07-30 WO disclosed
US-20080311187-A1 CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM GRUNENTHAL GMBH (DE) 2008-12-18 US disclosed
US-20060193914-A1 Crush resistant delayed-release dosage forms ENDO PHARMACEUTICALS, INC. 2006-08-31 US disclosed